Belzutifan
NCT04924075
Merck · Phase 2 · Recruiting · Enrollment 355
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Belzutifan
Merck · Phase 2 · Recruiting · Enrollment 355
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.